Furthermore, CD44v9 expression was correlated with the expression of inflammation-related markers, S100 calcium-binding protein P (S100P) and cyclooxygenase-2 (COX-2), suggesting that CD44v9 might be a novel CCA stem cell marker and may be involved in inflammation-related cancer progression [58]. The gene discussed is PTGS2; the disease is cholangiocarcinoma.